These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 30017813)

  • 1. Generation of high quality of hepatocyte-like cells from induced pluripotent stem cells with Parp1 but lacking c-Myc.
    Huang CS; Lin HC; Lu KH; Wu WW; Yang YC; Yang YP; Chiang CH; Hsieh JH; Chang YL; Lee SD
    J Chin Med Assoc; 2018 Oct; 81(10):871-877. PubMed ID: 30017813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reprogramming induced pluripotent stem cells in the absence of c-Myc for differentiation into hepatocyte-like cells.
    Li HY; Chien Y; Chen YJ; Chen SF; Chang YL; Chiang CH; Jeng SY; Chang CM; Wang ML; Chen LK; Hung SI; Huo TI; Lee SD; Chiou SH
    Biomaterials; 2011 Sep; 32(26):5994-6005. PubMed ID: 21658760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poly(ADP-ribose) polymerase 1 regulates nuclear reprogramming and promotes iPSC generation without c-Myc.
    Chiou SH; Jiang BH; Yu YL; Chou SJ; Tsai PH; Chang WC; Chen LK; Chen LH; Chien Y; Chiou GY
    J Exp Med; 2013 Jan; 210(1):85-98. PubMed ID: 23277454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of non-alcoholic steatohepatitis by hepatocyte-like cells generated from iPSCs with Oct4/Sox2/Klf4/Parp1.
    Chien Y; Huang CS; Lin HC; Lu KH; Tsai PH; Lai YH; Chen KH; Lee SD; Huang YH; Wang CY
    Oncotarget; 2018 Apr; 9(26):18594-18606. PubMed ID: 29719629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Artd1/Parp1 regulates reprogramming by transcriptional regulation of Fgf4 via Sox2 ADP-ribosylation.
    Weber FA; Bartolomei G; Hottiger MO; Cinelli P
    Stem Cells; 2013 Nov; 31(11):2364-73. PubMed ID: 23939864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs).
    Singh VK; Kumar N; Kalsan M; Saini A; Chandra R
    J Stem Cells; 2015; 10(1):43-62. PubMed ID: 26665937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced human somatic cell reprogramming efficiency by fusion of the MYC transactivation domain and OCT4.
    Wang L; Huang D; Huang C; Yin Y; Vali K; Zhang M; Tang Y
    Stem Cell Res; 2017 Dec; 25():88-97. PubMed ID: 29125994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reprogramming human endometrial fibroblast into induced pluripotent stem cells.
    Chen YJ; Liou YJ; Chang CM; Li HY; Chen CY; Twu NF; Yen MS; Chang YL; Peng CH; Chiou SH; Chen CP; Chao KC
    Taiwan J Obstet Gynecol; 2012 Mar; 51(1):35-42. PubMed ID: 22482966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of carbon tetrachloride-induced acute hepatic failure by transplantation of induced pluripotent stem cells without reprogramming factor c-Myc.
    Chang HM; Liao YW; Chiang CH; Chen YJ; Lai YH; Chang YL; Chen HL; Jeng SY; Hsieh JH; Peng CH; Li HY; Chien Y; Chen SY; Chen LK; Huo TI
    Int J Mol Sci; 2012; 13(3):3598-3617. PubMed ID: 22489170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of human foreskin fibroblast-derived induced pluripotent stem cells into hepatocyte-like cells.
    Wang J; Zhao P; Wan Z; Jin X; Cheng Y; Yan T; Qing S; Ding N; Xin S
    Cell Biochem Funct; 2016 Oct; 34(7):475-482. PubMed ID: 27569862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic regulation of human endogenous retroviruses mediates factor-induced reprogramming and differentiation potential.
    Ohnuki M; Tanabe K; Sutou K; Teramoto I; Sawamura Y; Narita M; Nakamura M; Tokunaga Y; Nakamura M; Watanabe A; Yamanaka S; Takahashi K
    Proc Natl Acad Sci U S A; 2014 Aug; 111(34):12426-31. PubMed ID: 25097266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promotion of direct reprogramming by transformation-deficient Myc.
    Nakagawa M; Takizawa N; Narita M; Ichisaka T; Yamanaka S
    Proc Natl Acad Sci U S A; 2010 Aug; 107(32):14152-7. PubMed ID: 20660764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-efficiency generation of induced pluripotent mesenchymal stem cells from human dermal fibroblasts using recombinant proteins.
    Chen F; Zhang G; Yu L; Feng Y; Li X; Zhang Z; Wang Y; Sun D; Pradhan S
    Stem Cell Res Ther; 2016 Jul; 7(1):99. PubMed ID: 27473118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using low-risk factors to generate non-integrated human induced pluripotent stem cells from urine-derived cells.
    Wang L; Chen Y; Guan C; Zhao Z; Li Q; Yang J; Mo J; Wang B; Wu W; Yang X; Song L; Li J
    Stem Cell Res Ther; 2017 Nov; 8(1):245. PubMed ID: 29096702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using Oct4:MerCreMer Lineage Tracing to Monitor Endogenous Oct4 Expression During the Reprogramming of Fibroblasts into Induced Pluripotent Stem Cells (iPSCs).
    Greder LV; Post J; Dutton JR
    Methods Mol Biol; 2016; 1357():97-110. PubMed ID: 25687297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional Reactivation of OTX2, RX1 and SIX3 during Reprogramming Contributes to the Generation of RPE Cells from Human iPSCs.
    Li P; Sun X; Ma Z; Liu Y; Jin Y; Ge R; Hao L; Ma Y; Han S; Sun H; Zhang M; Li R; Li T; Shen L
    Int J Biol Sci; 2016; 12(5):505-17. PubMed ID: 27019633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of Induced Pluripotent Stem Cells in Rabbits.
    Afanassieff M; Tapponnier Y; Savatier P
    Methods Mol Biol; 2016; 1357():149-72. PubMed ID: 25413017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of dental pulp-derived induced pluripotent stem cells in the absence of c-Myc for differentiation into neuron-like cells.
    Chang YC; Li WC; Twu NF; Li HY; Lo WL; Chang YL; Lee YY; Lin CF; Shih YH; Chen MT
    J Chin Med Assoc; 2014 Dec; 77(12):618-25. PubMed ID: 25441769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. H1foo Has a Pivotal Role in Qualifying Induced Pluripotent Stem Cells.
    Kunitomi A; Yuasa S; Sugiyama F; Saito Y; Seki T; Kusumoto D; Kashimura S; Takei M; Tohyama S; Hashimoto H; Egashira T; Tanimoto Y; Mizuno S; Tanaka S; Okuno H; Yamazawa K; Watanabe H; Oda M; Kaneda R; Matsuzaki Y; Nagai T; Okano H; Yagami KI; Tanaka M; Fukuda K
    Stem Cell Reports; 2016 Jun; 6(6):825-833. PubMed ID: 27237376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal reprogramming factor stoichiometry increases colony numbers and affects molecular characteristics of murine induced pluripotent stem cells.
    Tiemann U; Sgodda M; Warlich E; Ballmaier M; Schöler HR; Schambach A; Cantz T
    Cytometry A; 2011 Jun; 79(6):426-35. PubMed ID: 21548079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.